New Liver-Targeted chemo cocktail aims to stop colorectal cancer from coming back
NCT ID NCT07570914
First seen May 09, 2026 · Last updated May 20, 2026 · Updated 2 times
Summary
This study tests a combination of chemotherapy drugs given directly into the liver (hepatic arterial infusion) plus standard chemo pills and IV drugs after surgery to remove colorectal cancer that spread to the liver. The goal is to see if this approach can prevent the cancer from returning for at least 3 years. About 28 adults who have had successful surgery and show no remaining cancer will receive 2 to 4 cycles of this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.